Narrative review / 2013
Curcumin targets multiple cell signaling pathways involved in carcinogenesis and is safe and well tolerated even at high doses.
This review examines the mechanisms of curcumin, an active constituent of turmeric, in cancer prevention and treatment across various cancers. Curcumin modulates cell signaling pathways by interacting with transcription factors, growth factors, enzymes, kinases, and inflammatory cytokines, while upregulating proapoptotic and downregulating antiapoptotic proteins. Animal models and human studies have indicated that curcumin is safe and well tolerated even at very high doses.
- Study type
- Narrative review
- Who was studied
- Human studies and animal models
- What was measured
- Molecular pathways, safety, chemopreventive, and therapeutic effects of curcumin in various cancers
THE PAPER
Curcumin in various cancers.
Shehzad A, Lee J, Lee YS. Biofactors, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.